Research.Patient.info
Respiratory Syncytial Virus research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE2
Phase 2b Study of a Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Protein Vaccine Candidate in Adults 60 Years of Age and Older
This study is testing a new vaccine for adults aged 60 and over. It aims to protect against two common chest infections, RSV and HMPV. Researchers want to see how well it works and if it's safe. Half of the volunteers will get the vaccine, and half will get a dummy injection (placebo).
Australia · United Kingdom - active not recruitingPHASE1
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months
This study is testing new mRNA vaccines against common winter viruses, RSV and hMPV, in babies and toddlers aged 5 to 24 months. Researchers want to see if the vaccines are safe and good at triggering the body's immune response.
United States · Panama · United Kingdom